Mundipharma Research Limited
Clinical trials sponsored by Mundipharma Research Limited, explained in plain language.
-
New hope for aggressive brain cancer: early trial tests tinostamustine
Disease control CompletedThis early-phase study tested a new drug called tinostamustine in 10 people with a fast-growing brain cancer (glioblastoma) that has a specific genetic marker (unmethylated MGMT). The goal was to see if the drug is safe and how the body processes it, given after standard treatmen…
Phase: EARLY_PHASE1 • Sponsor: Mundipharma Research Limited • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New drug aims to shield transplant patients from deadly fungal infections
Prevention CompletedThis study tested whether a new drug called rezafungin can prevent serious fungal infections in adults receiving a bone marrow transplant. About 600 participants were given either rezafungin or the standard treatment. The goal was to see if rezafungin is safer and works better at…
Phase: PHASE3 • Sponsor: Mundipharma Research Limited • Aim: Prevention
Last updated May 01, 2026 16:00 UTC